Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 5/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10334627 | 0.87 | PPARG (0.54) | KLK7LMNACYP2D6SRCPPARG | |
| SCHEMBL9292744 | 0.84 | MMP8 (0.50) | KLK7LMNASMN1; SMN2POLBMEN1 | |
| SCHEMBL6170700 | 0.82 | LMNA (0.43) | LMNACYP2D6SRCMAPK1SRR | |
| SCHEMBL5520718 | 0.82 | LMNA (0.43) | LMNACYP2D6SRCMAPK1SRR | |
| SCHEMBL11380505 | 0.78 | KLK7 (0.40) | KLK7LMNASMN1; SMN2PPARGPPARA | |
| SCHEMBL5509575 | 0.78 | SLC6A2 (0.41) | LMNASMN1; SMN2MEN1KMT2ACHRM1 | |
| Hydrochloric Acid SCHEMBL11382393 | 0.77 | KLK7 (0.39) | KLK7LMNASMN1; SMN2PPARGPPARA | |
| SCHEMBL360653 | 0.75 | KLK7 (0.68) | KLK7LMNASMN1; SMN2CYP2D6POLB | |
| SCHEMBL360652 | 0.75 | KLK7 (0.68) | KLK7LMNASMN1; SMN2CYP2D6POLB | |
| SCHEMBL10335670 | 0.75 | POLB (0.49) | KLK7SMN1; SMN2PPARGPPARAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190133118-A1 | TIME-RELEASE-TYPE GRANULAR AGROCHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING SAME | BAYER CROPSCIENCE AKTIENGESSELSCHAFT (DE) | 2019-05-09 | — | — | US | disclosed |
| WO-2017186577-A1 | TIMED-RELEASE-TYPE GRANULAR AGROCHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING SAME | BAYER CROPSCIENCE AKTIENGESSELSCHAFT (DE) | 2017-11-02 | — | — | WO | disclosed |
| EP-3238540-A1 | TIMED-RELEASE-TYPE GRANULAR AGROCHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING SAME | Bayer CropScience Aktiengesellschaft (DE) | 2017-11-01 | — | — | EP | disclosed |
| EP-2731933-A2 | 2,3-DIPHENYL-VALERONITRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | Bayer Intellectual Property GmbH (DE) | 2014-05-21 | — | — | EP | disclosed |
| WO-2013010882-A2 | 2,3-DIPHENYL-VALERONITRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-24 | — | — | WO | disclosed |
| EP-2421371-A1 | USE OF PROPINEB AS BIRD REPELLENT | Bayer CropScience AG (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-20110269832-A1 | USE OF PROPINEB AS BIRD REPELLENT | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2011107443-A1 | USE OF PROPINEB FOR PHYSIOLOGICAL CURATIVE TREATMENT UNDER ZINC DEFICIENCY | BAYER CROPSCIENCE AG (DE) | 2011-09-09 | — | — | WO | disclosed |
| US-20110218107-A1 | Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency | BAYER CROPSCIENCE AG (DE) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190133118-A1 | TIME-RELEASE-TYPE GRANULAR AGROCHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING SAME | SLC18A1, GRN, SAMM50 | KLK7 913/4885LMNA 2067/4885SMN1; SMN2 3449/4885 |
| US-20110218107-A1 | Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency | PLPBP, ZFR, CTRB1 | KLK7 1873/4885LMNA 4573/4885SMN1; SMN2 3210/4885 |
| US-20110269832-A1 | USE OF PROPINEB AS BIRD REPELLENT | NMBR, EPHB4, EPHB1 | KLK7 860/4885LMNA 4337/4885SMN1; SMN2 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.